RNAi Therapeutics Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global RNAi Therapeutics Market is expected to record a value of US$1.15 billion in 2028, progressing at a CAGR of 10% during the forecast period 2022-2028.

RNAi refers to interfering RNA that is responsible for controlling and manipulating protein translation in cells. This RNAi is used to silence certain genes that cause disease. Currently, RNAi is gaining recognition for its ability to provide target-specific mechanisms to lead to superior therapeutic outcomes. This approach is widely used in drug development. Increasing investment in RNAi therapeutics development along with increasing prevalence of infectious diseases and chronic diseases is expected to drive RNAi therapeutics market growth during the forecast period. However, the high costs associated with the development of RNAi therapies are likely to restrain the growth of the market during the forecast period.

Market Segments

By Molecule Type

• Small Interfering RNAs (siRNA)
• MicroRNA (miRNA)

By Application

• Oncology
• Cardiovascular
• Respiratory Disorders
• Renal Diseases
• Genetic Disorders
• Neurodegenerative Disorders
• Infectious Diseases
• Others

By Route of Administration

• Pulmonary Delivery
• Intravenous Injections
• Intradermal Injections
• Intraperitoneal Injections

Key Players

• Alnylam Pharmaceuticals, Inc.
• Sanofi
• Olix Pharmaceuticals, Inc.
• Glaxosmithkline Plc.
• Benitec Biopharma
• Arbutus Biopharma Corporation
• Silence Therapeutics
• Rexahn Pharmaceuticals, Inc.
• Arrowhead Pharmaceuticals, Inc

Scope of the Report

The research study analyzes the global RNAi Therapeutics industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by RNAi Therapeutics Market Report

1. What was the RNAi Therapeutics Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of RNAi Therapeutics Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the RNAi Therapeutics Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.